Japan: Most Overbought and Oversold - Relative Price Score Update - Companies
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...
446 Views
Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2
Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index. In today’s report...
445 Views
Strong 1H FY18 – Hemlibra Approval for Non-Inhibitors to Boost Sales.
We reiterate our “Equal-weight” rating on the stock post 1H FY18 (YE Dec-18) earnings. Chugai reported strong 1H FY18 sales (+12.8% to ¥1b) due to...
409 Views
Opportunities in The (Overpriced) Japan Pharma Sector
As a defensive sector, Japan’s pharmaceutical sector has had an up-and-down time of it during the Abe era. In the early days of Abenomics, the...
148 Views
Global Equity Strategy: Opportunities in Japan, HK, & EM
In our April International Strategy, we explore the recent consolidation across global equity markets and examine the following opportunities...
194 Views